BioLife Solutions (NASDAQ: BLFS) net income
BioLife Solutions reported a net loss of $4.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $20.2m. Earnings per share were −$0.09.
BioLife Solutions's best year of the last 10 was fiscal 2020. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$4.6m | — | −4.8% | −$0.09 |
| 2024 | −$20.2m | — | −27.0% | −$0.44 |
| 2023 | −$68.0m | — | −100.0% | −$1.52 |
| 2022 | −$139.8m | — | −183.4% | −$3.29 |
| 2021 | −$8.9m | −549.2% | −7.5% | −$0.23 |
| 2020 | $2.0m | — | 4.1% | $0.07 |
| 2019 | −$1.7m | — | −6.1% | −$0.09 |
| 2018 | −$25.0m | — | −126.7% | −$1.56 |
| 2017 | −$2.5m | — | −22.8% | −$0.21 |
| 2016 | −$6.9m | — | −83.6% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
BioLife Solutions net income compared with its sector
By net income for its latest fiscal year, BioLife Solutions ranks 180th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of BioLife Solutions, −4.8%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 178th | Agenus | −$3.1m | −2.7% |
| 179th | Omeros | −$3.4m | — |
| 180th | BioLife Solutions | −$4.6m | −4.8% |
| 181st | ETON Pharmaceuticals | −$4.6m | −5.8% |
| 182nd | Harrow | −$5.1m | −1.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of BioLife Solutions
- How much did BioLife Solutions earn in fiscal 2025?
- BioLife Solutions reported a net loss of $4.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $20.2m.
- What are the earnings per share of BioLife Solutions?
- They were −$0.09 in fiscal 2025, compared with −$0.44 in fiscal 2024.
- What was the most profitable year for BioLife Solutions?
- Of its last 10 fiscal years, fiscal 2020, with $2.0m.
- Where does BioLife Solutions rank in its sector by net income?
- It ranks 180th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for BioLife Solutions come from?
- From the annual report (Form 10-K) that BioLife Solutions files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that BioLife Solutions files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on BioLife Solutions: the BioLife Solutions page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.